Circulating nucleic acids, encapsulated within small extracellular vesicles (EVs), provide a remote cellular snapshot of biomarkers derived from diseased tissues, however selective isolation is critical. Current laboratoryâbased purification techniques rely on the physical properties of smallâEVs rather than their inherited cellular fingerprints. We established a highlyâselective purification assay, termed EVâCATCHER, initially designed for highâthroughput analysis of lowâabundance smallâRNA cargos by nextâgeneration sequencing. We demonstrated its selectivity by specifically isolating and sequencing smallâRNAs from mouse smallâEVs spiked into human plasma. Western blotting, nanoparticle tracking, and transmission electron microscopy were used to validate and quantify the capture and release of intact smallâEVs. As proofâofâprinciple for sensitive detection of circulating miRNAs, we compared smallâRNA sequencing data from a subset of smallâEVs serumâpurified with EVâCATCHER to data from whole serum, using samples from a small cohort of recently hospitalized Covidâ19 patients. We identified and validated, only in smallâEVs, hsaâmiRâ146a and hsaâmiRâ126â3p to be significantly downregulated with disease severity. Separately, using convalescent sera from recovered Covidâ19 patients with high antiâspike IgG titers, we confirmed the neutralizing properties, against SARSâCoVâ2 in vitro, of a subset of smallâEVs serumâpurified by EVâCATCHER, as initially observed with ultracentrifuged smallâEVs. Altogether our data highlight the sensitivity and versatility of EVâCATCHER.